Hassig Christian

Chief Scientific OfficerBoundless Bio, Inc. (BOLD) · full profile →Form 4 · filed Aug 20, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
0 non-derivative · 10 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 19, 2024Grant(A)10K10K
Aug 19, 2024Grant(A)63K63K
Aug 19, 2024Disposed to issuer(D)10K0
Aug 19, 2024Disposed to issuer(D)63K0
Aug 19, 2024Disposed to issuer(D)95K0
Aug 19, 2024Disposed to issuer(D)76K0
Aug 19, 2024Disposed to issuer(D)49K0
Aug 19, 2024Grant(A)49K49K
Aug 19, 2024Grant(A)76K76K
Aug 19, 2024Grant(A)95K95K

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-099308) within minutes of acceptance. Every field above traces to the original document. Verify it directly: